A patient who sought treatment for coronavirus symptoms in late February was left with a medical bill of $34,927.43 for testing and treatment.

CMS is providing exceptions from Medicare reporting requirements as well as extensions for clinicians and providers in Medicare quality reporting programs and data submission as the nation’s healthcare providers deal with the coronavirus pandemic.

Medicaid has undergone significant changes over the last several years, both after states were allowed to expand the federal program under the Affordable Care Act and after President Trump recently announced states will be allowed to cap spending for the program.

The state of Washington is the second states to receive an approved Section 1135 Medicaid waiver from CMS to help deal with the COVID-19 pandemic.

Another healthcare company is leveraging AI to address the new coronavirus pandemic and help identify potential patients who could have the virus.

As the new coronavirus, COVID-19, continues to spread across the globe and the number of infections in the U.S. rises daily, healthcare industry groups are continuing to ramp up recommendations, guidance and pressure on policymakers and regulators to ensure healthcare providers are able to respond swiftly to the crisis with flexibility.

HHS is bringing together a public-private partnership to address emergency drug packaging with a U.S.-based solution using low-cost prefilled syringes.

Venture capital investment volume and value continued to flow into the AI technology space in 2019, though the number of big deals dropped globally.